INTRABIOTICS PHARMACEUTICALS INC /DE

INTRABIOTICS PHARMACEUTICALS INC /DE insiders are currently net buyers of IBPI stock, showing bullish sentiment over the past 90 days. Executives have purchased $8.0M while selling $1.8M, resulting in a positive net flow of $6.2M. This buying activity represents 82% of total transaction volume.

INTRABIOTICS PHARMACEUTICALS INC /DE has 11 active insiders who have filed SEC Form 4 transactions in the past 90 days. Capital Management Llc Tang (Executive) leads with 13 transactions totaling $3.1M. Capital Group Llc Kellogg (Executive) follows with 2 transactions worth $2.2M. Open-market purchases require insiders to invest their own capital, demonstrating genuine conviction.

The Insider Alignment Score measures the ratio of buying to selling activity on a 0-100 scale. INTRABIOTICS PHARMACEUTICALS INC /DE's current score of 82/100 indicates bullish insider sentiment. Scores above 60 suggest insiders are accumulating shares faster than selling, reflecting $8.0M in purchases versus $1.8M in sales.

The most recent insider transaction occurred on Jan 25, 2007, when Capital (gp), Llc Baker Biotech (Executive) acquired 12,701 shares at $6.00 per share for $76.2K. This appears to be a discretionary trade.

Based on SEC Form 4 filings from the past 90 days, IBPI insider trading sentiment is currently bullish with an Alignment Score of 82/100. The net insider flow of $6.2M reflects accumulation, with 82% of volume being purchases.

SEC Form 4 is the primary disclosure mechanism for insider trading at publicly traded companies like INTRABIOTICS PHARMACEUTICALS INC /DE. Corporate insiders must file within two business days of any transaction, making it one of the most timely sources of executive sentiment. At IBPI, we track all Form 4 filings—currently showing 75 transactions from 11 insiders over 90 days.

A 10b5-1 plan allows INTRABIOTICS PHARMACEUTICALS INC /DE executives to pre-schedule stock sales when they don't possess material non-public information. At IBPI, approximately 0% of recent transactions are 10b5-1 trades. Most trading activity at IBPI appears discretionary, making insider signals more meaningful.

You can monitor INTRABIOTICS PHARMACEUTICALS INC /DE (IBPI) insider trading activity on this page, which updates within hours of new SEC Form 4 filings. We track all 11 active insiders and provide real-time transaction feeds, the Alignment Score, 10b5-1 vs. discretionary breakdowns, and direct links to SEC EDGAR filings.

Our Alignment Score measures the ratio of insider buying to selling on a scale of 0-100. A score above 70 indicates strong bullish sentiment, while below 30 suggests bearish activity. INTRABIOTICS PHARMACEUTICALS INC /DE's current score of 82/100 indicates strong bullish sentiment with executives accumulating shares. This is calculated from $8.0M in purchases versus $1.8M in sales over 90 days, resulting in a net flow of $6.2M.

SEC Form 4 filings are mandatory reports that INTRABIOTICS PHARMACEUTICALS INC /DE insiders must submit within 2 business days. Each filing includes the insider's name, relationship, transaction type, shares, and price. Transaction codes: P (purchase), S (sale), A (award), M (option exercise), G (gift). At IBPI, the most common type is "P" with 46 occurrences. The most recent Form 4 was filed on Jan 25, 2007 by Capital (gp), Llc Baker Biotech.

Rule 10b5-1 allows corporate insiders to establish pre-scheduled trading plans when they don't possess material non-public information. At INTRABIOTICS PHARMACEUTICALS INC /DE, approximately 0% of recent transactions are executed under 10b5-1 plans, while 100% appear to be discretionary trades. The low percentage means most insider activity at IBPI represents discretionary decisions with more informational value.